Eltrombopag enables initiation and completion of pegylated interferon/ribavirin therapy in Japanese HCV-infected patients with chronic liver disease and thrombocytopenia

To investigate the efficacy of eltrombopag for the treatment of thrombocytopenia in patients with chronic hepatitis C, a phase II, single-arm, open-label study with a 9-week pre-antiviral phase was conducted, followed by a 48-week antiviral phase and a 24-week follow-up phase. The proportion of pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawaguchi, Takumi, Komori, Atsumasa, Fujisaki, Kunio, Nishiguchi, Shuhei, Kato, Michio, Takagi, Hitoshi, Tanaka, Yasuhito, Notsumata, Kazuo, Mita, Eiji, Nomura, Hideyuki, Shibatoge, Mitsushige, Takaguchi, Koichi, Hattori, Toshihiro, Sata, Michio, Koike, Kazuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6566053/
https://www.ncbi.nlm.nih.gov/pubmed/31258695
http://dx.doi.org/10.3892/etm.2019.7616

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6566053/
https://www.ncbi.nlm.nih.gov/pubmed/31258695
http://dx.doi.org/10.3892/etm.2019.7616

Ejemplares similares